Safety assessment of medicines available in the ‘Brazilian list of essential medicines’ in the older persons according to the Beers Criteria
Authors:
- Francelle Adorno Sôffa Guimarães MonteiroFMFrancelle Adorno Sôffa Guimarães Monteiro
- Gabriela Mesquita PontesGPGabriela Mesquita Pontes
- Gilsiane de Sousa SampaioGSGilsiane de Sousa Sampaio
- Maria Eugênia Ribeiro Carvalho de OliveiraMOMaria Eugênia Ribeiro Carvalho de Oliveira
- Paulo Marcelo de Andrade LimaPLPaulo Marcelo de Andrade Lima
- 1 January 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 17, 1-9
Abstract
Objective: To describe the safety of medicines available in the “Brazilian List of Essential Medicines” (RENAME/2022) for the main comorbidities that affect older persons according to the Beers criteria 2019. Methods: Medicines listed in RENAME and recommended by the respective Brazilian medical guidelines for the treatment of hypertension, heart failure, diabetes, and neurological/ psychiatric diseases were evaluated for their safety profiles according to the Beers criteria 2019. Results: Fifty-eight out of 529 medicines in RENAME were evaluated. Of these, 29 were included in any of the Beers criteria: 20 were classified as potentially inappropriate, 17 should be avoided due to disease exacerbation, and 14 needed to be used with caution. Considering drugs used to treat cardiovascular, diabetes, and neurological/psychiatric disorders, 40.00, 37.50 and 60.00% respectively, had some criterion for their appropriate use in older persons. Conclusion: RENAME presents alternatives for the safe treatment of older patients. In the treatment of cardiovascular diseases, diabetes, and neurodegenerative diseases, the firstchoice recommendations are available in RENAME. Regarding psychiatric disorders, safe pharmacological alternatives are still scarce and need to be better discussed.Keywords
This publication has 26 references indexed in Scilit:
- A Systematic Review of the Impact of Potentially Inappropriate Medication on Health Care Utilization and Costs Among Older AdultsMedical Care, 2016
- Quetiapine safety in older adults: a systematic literature reviewJournal of Clinical Pharmacy and Therapeutics, 2016
- Avaliação de oito Protocolos Clínicos e Diretrizes Terapêuticas (PCDT) do Ministério da Saúde por meio do instrumento AGREE II: um estudo pilotoCadernos de Saude Publica, 2015
- Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐AnalysisJournal of the American Geriatrics Society, 2015
- Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population‐based estimatesBritish Journal of Clinical Pharmacology, 2015
- The Prevalence of Disease Clusters in Older Adults with Multiple Chronic Diseases – A Systematic Literature ReviewPLOS ONE, 2013
- Atualização da diretriz brasileira de insuficiência cardíaca crônica - 2012Arquivos Brasileiros de Cardiologia, 2012
- A Secretaria de Ciência e Tecnologia e Insumos Estratégicos do Ministério da Saúde e a pesquisa em alimentação e nutriçãoCadernos de Saude Publica, 2008
- V Diretrizes Brasileiras de Hipertensão ArterialArquivos Brasileiros de Cardiologia, 2007
- Antipsychotic Medications and the ElderlyDrugs & Aging, 2001